Home > Gastroenterology > ECCO 2019 > Short-term and Long-term Treatment Results > The right drug for the right patient

The right drug for the right patient

Expert
Dr Charlie Lees, Western General Hospital, United Kingdom
Conference
ECCO 2019
Trial
PROFILE

The ever-increasing armamentarium for the treatment of inflammatory bowel disease (IBD) poses an 'embarrassment of riches', as Dr Charlie Lees (Western General Hospital, United Kingdom) put it. He discussed stratification by disease biology to choose the right drug for the right patient.

It has been neglected for too long that IBD is progressive, according to Dr Lees; the typical pattern being: Patients are diagnosed with active disease, remission is induced but without properly controlling inflammation, the disease will flare and evolve over time. “Once we realise we must not only treat symptoms but also underlying inflammation, we can finally change the natural history of the disease course and offer our patients a much better outlook,” he said. “This means treating early, reducing flare rate, and getting close to a cure for some of our patients. Therefore, early control is everything.” Proof for this concept has emerged from numerous studies of drugs em...



please login to read the entire article:


You need to register to read the entire article, please do so now.





Posted on